Kleiner Perkins Dialing Up Activity in Boston?
So I wanted to check if that was true.
When I asked KP's PR person if there was anyone based out here permanently, or an office that they'd set up in Boston, their reply via e-mail was, "KPCB’s official offices are in China and California. There is a plethora of innovation happening in the Boston area, and KPCB is involved in identifying new ideas and helping to build companies." They apologized for not being able to share more details.
Greeley mentioned that Tom Monath (formerly chief scientific officer at Acambis) is on the KP team, and based in Boston. KP wouldn't confirm that. But here's a two-year-old Mass High Tech article mentioning that they'd brought Monath on board, and were opening an office. But Monath seems to live in Harvard, Mass., and I couldn't find a listing for KP in the Boston area, though he is still listed on KP's Web site as a partner in the firm's "pandemic and biodefense fund." (He didn't respond to my e-mail last week.)
What Kleiner does have locally is a "strategic partnership" with GreatPoint Ventures in Cambridge. Kleiner doesn't have money in the GreatPoint fund, but they do get a first look at "interesting deals we bring them," according to Aaron Mandell of Great Point. That arrangement has been in place for "about six months," he said. They've invested together in GreatPoint Energy and Alta Rock Energy, a geothermal energy company. Mandell said GreatPoint is definitely not an affiliate or "branch office" of KP...
Among Kleiner's Massachusetts portfolio companies are CodonDevices, Bit9, Epizyme, Mascoma, Upromise (acquired by Sallie Mae), and Lilliputian Systems, which just yesterday announced plans to expand its manufacturing facility and add about 100 jobs.
Are you hearing about other KP activity in town? Post a comment if you would....
Labels: Aaron Mandell, Acambis, Flybridge Capital Partners, GreatPoint Energy, GreatPoint Ventures, Kleiner Perkins, Lilliputian Systems, Michael Greeley, Tom Monath